Arturo Araya

Arturo Araya is the Chief Commercial Officer at Brainstorm Cell Therapeutics. Arturo has over 19 years of experience in the healthcare industry, with a focus on cell and gene therapies. Prior to joining Brainstorm, Arturo was a consultant with Savicore Healthcare Consulting, where they advised clients on commercialization strategy and expansion. Arturo also served as the Chief Commercial Officer for the Cell & Gene Therapies Unit at Novartis, where they oversaw the commercialization of Novartis' cell and gene therapy products. Arturo has also served on the Board of Directors for Brainstorm Cell Therapeutics since September 2018.

Arturo Araya has an MBA in marketing and finance from the University of Michigan - Stephen M. Ross School of Business, a MA in political science from the University of Connecticut, and a BS in civil engineering from the University of Connecticut.

Arturo Araya works with Revital Aricha - VP Research & Development, Susan E. Ward - Head Of Clinical Operations, and Ralph Kern - Chief Operating Officer and Chief Medical Officer. Their manager is Chaim Lebovits, President & CEO.